TOPIC main outcomes: Efficacy and safety of once-daily oral teriflunomide in patients with clinically isolated syndrome

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2013
This article has no abstract
Epistemonikos ID: e29cd061f54e3f51f1224d3a5361ea374987fa9a
First added on: Apr 30, 2026